Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6495
    -0.0005 (-0.07%)
     

  • OIL

    82.40
    -0.41 (-0.50%)
     

  • GOLD

    2,332.80
    -5.60 (-0.24%)
     

  • Bitcoin AUD

    97,448.28
    -4,132.42 (-4.07%)
     

  • CMC Crypto 200

    1,370.06
    -12.52 (-0.91%)
     

  • AUD/EUR

    0.6068
    -0.0002 (-0.03%)
     

  • AUD/NZD

    1.0957
    +0.0015 (+0.14%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,236.41
    -290.39 (-1.66%)
     

  • FTSE

    8,053.26
    +12.88 (+0.16%)
     

  • Dow Jones

    37,815.58
    -645.34 (-1.68%)
     

  • DAX

    17,847.03
    -241.67 (-1.34%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Company News for Feb 1, 2023

Zacks Equity Research
·1-min read

  • Shares of Exxon Mobil Corp. XOM gained 2.2% after the company reported fourth-quarter 2022 adjusted earnings per share of $3.40, beating the Zacks Consensus Estimate of $3.32.

  • Shares of Pfizer Inc. PFE rose 1.4% after the company posted fourth-quarter 2022 adjusted earnings per share of $1.14, surpassing the Zacks Consensus Estimate of $1.03.

  • Caterpillar Inc.’s CAT shares tumbled 3.5% after reporting fourth-quarter 2022 adjusted earnings per share of $3.86, missing the Zacks Consensus Estimate of $3.95.

  • General Motors Co.’s GM shares climbed 8.4% after posting fourth-quarter 2022 adjusted earnings per share of $$2.12, outpacing the Zacks Consensus Estimate of $1.68.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Caterpillar Inc. (CAT) : Free Stock Analysis Report

Exxon Mobil Corporation (XOM) : Free Stock Analysis Report

Pfizer Inc. (PFE) : Free Stock Analysis Report

General Motors Company (GM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research